Загрузка видео...

Не удалось загрузить видео

На главную

🚨🚨🚨BREAKING🚨🚨🚨 #LMHRstudy / KETO-CTA published! 100 lean, metabolically healthy #keto: 🔥 No association of #ApoB with #plaque ↗️ 🔥 No association of #LDL #cholesterol with #plaque ↗️ 🫀What is association? Existing plaque Read and share 👇👇👇

Комментарии: 11

Фото профиля ⭐Fernando Martel García, PhD
⭐Fernando Martel García, PhD1 год назад

That "plaque begets plaque" is a very unsatisfying explanation. So what starts the plaque in the first place?

Фото профиля Dave Feldman
Dave Feldman1 год назад

A crucial question -- but these data are more about looking to our cohort and whether the association of LDL/ApoB is present...

Фото профиля Hungryroot
Hungryroot1 год назад

"My cholesterol is 1/3 of what it was, I have lost 20 lbs and I feel amazing every day!" - Jessica K, Customer Review

Фото профиля Iain Campbell, Ph.D.
Iain Campbell, Ph.D.1 год назад

Congratulations Dave, @nicknorwitz, @AdrianSotoMota! 👏 What an incredible journey to bring this from personal experience to published research. Looking forward to the documentary!

Фото профиля Twyla Honey
Twyla Honey1 год назад

Congrats 🎉 My cholesterol 325 LDL 215 Triglycerides 64 (Do you want my other lipid panel results?) MD said statins. I said following you and requested CT Calcium Scoring Scan. Results 1 (one). 7 years lc Keto. Thank you for saving me from statins. Will give paper to my MD.

Фото профиля Metabolic Mind
Metabolic Mind1 год назад

Congrats on the publication @realDaveFeldman; this research is a game-changer for so many people out there!

Фото профиля Dave Feldman
Dave Feldman1 год назад

🙏 🙏 🙏

Фото профиля Vatsal G. Thakkar MD
Vatsal G. Thakkar MD1 год назад

Thanks for your work on this!

Фото профиля Dave Feldman
Dave Feldman1 год назад

Can't even believe how long I've waited for this -- and now the day has arrived.

Фото профиля Dr. Stephen Hussey, DC
Dr. Stephen Hussey, DC1 год назад

Good stuff, Dave. I'd posit that the presence of plaque leads to plaque progression because it changes blood flow dynamics.

Фото профиля Eric Rodgers
Eric Rodgers1 год назад

Fantastic summary in your video above 😀 Amazing milestone in your epic journey towards helping others.

Похожие видео

🚨🚨🚨🚨🚨🚨🚨🚨 BREAKING: Matthew Budoff MD has now presented the matched analysis for: KETO (#LMHRstudy) vs Control (#MiHeart) -🙏Please RT🙏- METHODS – 80 Participants of #LMHRstudy fell within #MiHeart age range and were then matched 1:1 for age, gender, race, diabetes mellitus, hyperlipidemia, hypertension, and past smoking to asymptomatic subjects from the #MiHeart cohort. PRIMARY ANALYSIS – High resolution heart scans (#CCTA) allowing for primary analysis of Total Plaque Score (TPS), Total Stenosis Score (TSS) and Segment Involvement Score (SIS) RESULTS The matched mean age was 55.5 years, with mean #LDL cholesterol of 272 mg/dL (max LDL-C 591) mg/dl and mean 4.7 years duration on a ketogenic diet. 🚨 There was no significant difference in coronary plaque burden of #LMHRstudy (mean LDL-C 272) cohort as compared to #MiHeart controls (mean LDL 123 mg/dl); nb: pre-KETO LDL-C in KETO group was 122 mg/dl 🚨 There was no significant difference in CAC (median and IQR) [0 (0,56)] versus [1 (0, 49)], p = 0.520 🚨 No relationship of LDL-C elevations and plaque ⚠️ This analysis is on baseline scans and the study is still ongoing for second CCTA completion in our cohort by February of 2024. And as always, please continue to work with your doctor. - I will have my own video reaction and thoughts in the coming hours. 🙏🙏🙏 to everyone -- and I mean everyone -- who helped us get to this pivotal milestone. 🙏🙏🙏

Dave Feldman

1,105,534 просмотров • 2 лет назад

There’s been a lot of buzz—and confusion—about the new Keto-CTA study, examining plaque progression in Lean Mass Hyper-Responders (LMHRs). Much of the social media debate has centered on whether high LDL on keto is safe or dangerous, driven largely by how to interpret the supplemental table comparing this study to others on LDL and plaque progression. In this episode of the Metabolic Mind Podcast, we sit down with Dr. Matthew Budoff, a world-renowned cardiologist, cardiac CT researcher, and the study's lead investigator, to discuss the the supplemental table, what the plaque markers mean, and how this fits into the discussion of high- vs -low-risk plaque progression. In this episode, we cover: ✅ What PAV (Percent Atheroma Volume) is, what it actually measures, and why it matters ✅ Why a 50% increase in plaque may sound scary, but can be deceiving ✅ The difference between “treatment-naive” and “treated” participants ✅ What the Miami Heart Study comparison reveals about keto, LDL, and plaque ✅ Why LDL alone may not tell the whole story about heart disease risk ✅ How some high-risk individuals may still benefit from statins and other therapies This study doesn’t answer whether keto causes heart disease or not. Instead, it shows that high LDL on a ketogenic diet is not a reliable predictor of plaque progression across all individuals. What is predictive? The presence of existing plaque. 💡 Key takeaway: Relying on surrogate markers of heart disease, like LDL and ApoB, is not the best way to assess heart disease risk in all populations. If you're concerned about how elevated LDL may be affecting your heart health, the best next step is to speak with your doctor about cardiac imaging to directly assess plaque and gain a clearer picture of your individual risk. Expert Featured: - Dr. Matthew Budoff - X: - Resources Mentioned: Plaque Begets Plaque, ApoB Does Not CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at

Metabolic Mind

98,147 просмотров • 1 год назад